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Abstract
Polymer hydrogels are ideal scaffolds for both tissue engineering and drug delivery. A great advantage of poly(amino acid)-based
hydrogels is their high similarity to natural proteins. However, their expensive and complicated synthesis often limits their applica-
tion. The use of poly(aspartic acid) (PASP) seems an appropriate solution for this problem due to the relatively cheap and simple
synthesis of PASP. Using amino acids not only as building blocks in the polymer backbone but also as cross-linkers can improve
the biocompatibility and the biodegradability of the hydrogel. In this paper, PASP cross-linked with cystamine (CYS) and lysine-
methylester (LYS) was introduced as fully amino acid-based polymer hydrogel. Gels were synthesized employing six different
ratios of CYS and LYS. The pH dependent swelling degree and the concentration of the elastically active chain were determined.
After reduction of the disulfide bonds of CYS, the presence of thiol side groups was also detected. To determine the concentration
of the reactive cross-linkers in the hydrogels, a new method based on the examination of the swelling behavior was established.
Using metoprolol as a model drug, cell proliferation and drug release kinetics were studied at different LYS contents and in the
presence of thiol groups. The optimal ratio of cross-linkers for the proliferation of periodontal ligament cells was found to be
60−80% LYS and 20−40% CYS. The reductive conditions resulted in an increased drug release due to the cleavage of disulfide
bridges in the hydrogels. Consequently, these hydrogels provide new possibilities in the fields of both tissue engineering and con-
trolled drug delivery.
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Introduction
The number of medical applications of polymer hydrogels in-
creased substantially during the last decades due to their simi-
larity to soft tissues [1-3]. Polymer hydrogels possess proper-
ties of solid materials such as deformability and rigidity, but at
the same time they are permeable for small molecules. One of
the most beneficial properties of polymer hydrogels is that they
are sensitive to alterations of the local environmental condi-
tions, such as the pH value or temperature. Polymer hydrogels
can change their swelling degree depending on the changing
environmental conditions. Therefore, hydrogels can be used as
drug delivery systems [4], implants [5,6], coatings [7,8] or scaf-
folds for tissue engineering [2,3,9,10]. Besides these stimuli-
responsive properties, the chemical and physical structure, the
mechanical properties [10] as well as biocompatibility and
biodegradability are also fundamental features of polymers de-
veloped for numerous medical applications [11,12].
Polymer hydrogels are capable of releasing physically
entrapped drug molecules. The release kinetics of the loaded
drug molecules depend significantly on the swelling degree of
the polymer matrix [13-16]. Recently, smart hydrogels showing
strong and abrupt responses (changes in their swelling degree)
to small changes of the environmental conditions have been the
subject of extensive research [17-22].
The composition of the polymer backbone determines almost
all of the properties of the hydrogels. For biological applica-
tions, in general, the polymer backbone and its degradation
products have to be biodegradable and biocompatible [11,23].
In contrast to many synthetic polymers, the degradation prod-
ucts of poly(amino acid)s, which are mainly built from only one
or two types of amino acids, are biocompatible nutrients. In ad-
dition, poly(amino acid)s have enormous structural diversity
and they supposedly lack immunogenicity [24,25]. In summary,
the use of poly(amino acid)s has practically only one disadvan-
tage: their synthesis is usually complicated and expensive [3].
Recently, various types of polymer-based hydrogels have been
developed for purposes of tissue engineering and regenerative
medicine [26]. Most of these polymers try to mimic or recreate
the natural environment of the cells, namely the extracellular
matrix (ECM) [27]. Among them, synthetic, amino acid-based
polymers attract particular attention due to their tunable proper-
ties and the structural similarity to the native ECM [26]. The
poly(amino acid)s being tested for biomedical applicability can
be classified into three groups: anionic, cationic and neutral
poly(amino acid)s [28,29]. The effect of poly-ʟ-lysine, which
has a cationic character, on the cell behavior has been widely
studied in the field of tissue engineering [30,31], while among
the anionic poly(amino acid)s, poly(glutamic acid) is typically
used for the development of hydrogel scaffolds [32]. Moreover,
our research group demonstrated previously that hydrogels
based on the anionic poly(aspartic acid) (PASP) are also well-
suited for tissue engineering purposes [25].
Another field of potential biomedical applications of poly-
(amino acid)s is drug delivery. Poly(amino acid)-based micro-
carriers can improve the pharmacological and therapeutic prop-
erties of various drugs [28]. By applying such microcarriers, the
drug release kinetics can be controlled. Among the anionic
amino acids, glutamic acid was previously used for the prepara-
tion of polymer-based microcarriers [33]. However, there are
only sporadic data available regarding PASP-based drug
delivery systems [34-37].
Although the preparation of most types of poly(amino acid)s is
expensive, the synthesis of PASP can be relatively cost-effi-
cient, and it does not require extreme conditions, as we de-
scribed previously [25,37-40]. In the last decades, the interest of
scientists in PASP-based hydrogels increased significantly due
to their potential applications in medical, pharmaceutical and
environmental fields [25,34,41-44]. Several publications can be
found concerning different types of cross-linkers to prepare
PASP-based hydrogels [22,34,45]. However, the number of
studies describing the use of pure amino acids or amino acid de-
rivatives as cross-linkers is limited [22,46]. For hydrogels made
of fully amino acid-based polymers, biodegradability as well as
biocompatibility could be improved due to their specific chemi-
cal composition. In our previous publications, we presented the
synthesis of PASP and several preparation methods of PASP-
based hydrogels based on cross-linking with diaminobutane
(DAB) and CYS in two-step reactions [21,22,25]. The chemi-
cal [22], swelling [13], mechanical and responsive properties
[21] of these gels as well as their applicability as scaffolds for
osteosarcoma cells (MG-63) [25] have been investigated. We
showed that MG-63 cells can proliferate on PASP-based hydro-
gels [25], which led to the idea that similar fully amino
acid-based gels may also support the growth of untransformed
cells.
In the present study, derivatives based exclusively on amino
acids, namely, on lysine-methylester (LYS) and CYS, were
used as cross-linkers for preparing PASP-based hydrogels. CYS
is biologically active and can provide free thiol groups under re-
ductive conditions, while the advantage of LYS is that it can
partially decrease the anionic character of aspartic acid. In addi-
tion, LYS also facilitates the electrostatic interaction between
anionic plasma membrane sites and cationic polymer sites.
Therefore, it supports cell adhesion and proliferation [47]. The
swelling, mechanical and degradation properties of the gels
Beilstein J. Nanotechnol. 2019, 10, 2579–2593.
2581
Table 1: The applied amounts of the various components during the gel synthesis.
Gel sample PSI solution (mg) CYS·2HCl (mg) LYS·2HCl (mg) DMSO (μL) DBA (μL)
PSI-100CYS-LYS 600 17.4 0.0 325.5 26.1
PSI-80CYS-LYS 600 13.9 3.6 325.4 26.1
PSI-60CYS-LYS 600 10.4 7.2 325.3 26.1
PSI-40CYS-LYS 600 7.0 10.8 325.1 26.1
PSI-20CYS-LYS 600 3.5 14.4 325.0 26.1
PSI-0CYS-LYS 600 0.0 18.0 324.9 26.1
containing LYS and CYS at different ratios were investigated
since these attributes are crucial for biomedical applications.
The swelling degree was determined at different pH values and
under redox conditions. For biocompatibility studies, cell
viability tests were carried out using primary cultures of human
periodontal ligament-derived cells (PDLCs) instead of the pre-
viously used tumor cell line. Periodontal ligament as a source of
stem-like cells is easily accessible during surgical removal of
wisdom teeth [48]. PDLCs hold great promise for application in
the field of tissue engineering [49]. Cell viability was assessed
using the WST-1 reagent [2-(4-iodophenyl)-3-(4-nitrophenyl)-
5-(2,4-disulfophenyl)-2H-tetrazolium] (Roche, Switzerland),
while the cell morphology was observed under a two-photon
microscope. Moreover, the release kinetics of the model drug
metoprolol were also examined under various environmental
conditions.
Experimental
Materials
Following materials have been used in this study: ʟ-aspartic
acid (CAS: 56-84-8, Aldrich, ≥98%), orthophosphoric acid
(CAS: 7664-38-2, Aldrich, ≥99%), dimethylformamide (CAS:
68-12-2, VWR, ≥99.9%) cystamine dihydrochloride (CAS:
56-17-7, Fluka, ≥98%), lysine methyl ester dihydrochloride
(CAS: 26348-70-9, Bachem, 97%), dimethyl sulfoxide (CAS:
67-68-5, VWR, ≥99%), dibutylamine (CAS: 111-92-2, Aldrich,
≥99.5%), citric acid monohydrate (CAS: 5949-29-1, VWR,
100%, normapur), imidazole (CAS.288-32-4, Sigma-Aldrich,
≥99.5%, puriss), sodium chloride (CAS: 7647-14-5, Sigma-
Aldrich, puriss), sodium hydroxide (CAS: 1310-73-2, Reanal,
puriss), borax (CAS: 1303-96-4, Hungaropharma, ≥99.5%),
disodium hydrogen phosphate (CAS: 7558-79-4, Sigma-
Aldrich, ≥98%), trisodium phosphate (CAS: 10101-89-0,
Sigma-Aldrich, ≥98%), phosphate-buffered saline (PBS)
tablet (Sigma), ᴅʟ-dithiothreitol (CAS: 3483-12-3, Sigma,
≥99%).
Synthesis of poly(succinimide)
Poly(succinimide) (PSI) was synthesized by thermal polycon-
densation of the mixture of ʟ-aspartic acid and orthophosphoric
acid. The mixture was loaded into a 1 L flask and inserted into a
rotary evaporator (IKA). The temperature was increased to
180 °C while the pressure was decreased to 5 mbar. After 7 h,
brown foam was gained, which was dissolved in dimethylform-
amide (DMF). Subsequently, the solution was precipitated,
washed with distilled water and finally dried at 40 °C. Details
of this method were published previously [25,37,38].
Simultaneous cross-linking of PSI by CYS
and LYS
PSI was dissolved in dimethyl sulfoxide (DMSO) at a concen-
tration of 25 wt % and mixed with the cross-linker solution,
which contained cystamine dihydrochloride (CYS·2HCl) and
lysine methyl ester dihydrochloride (LYS·2HCl) at different
ratios in DMSO (Table 1). During cross-linking, the free prima-
ry amino groups of the cross-linkers react with the imide groups
of the succinimide rings in a nucleophilic addition reaction
(Figure 1, step 1). Dibutylamine (DBA) was added to the reac-
tion mixture in order to adjust the pH value.
The mixture was loaded into glass frames in order to prepare
gel films. After 24 h, the gelation occurred and every sample
had a PSI content of 15 wt % at a theoretical degree of 20 cross-
links. The degree of cross-links is defined as the molar ratio of
monomers and cross-linking agents. The reaction of the gel for-
mation is shown in Figure 1, step 1.
Six gel types were prepared with different ratio of the cross-
linking agents (Table 1). The number in the name of the sam-
ples indicates the molar percentage of CYS of the total amount
of cross-linking agents. For example, PSI-100CYS-LYS
contains only CYS while in the case of PSI-0CYS-LYS, only
LYS was used as cross-linking agent.
Preparation of PASP-based hydrogels
PASP-based hydrogels were formed by mild alkaline hydroly-
sis of the PSI gels. The gels were immersed into an imidazole-
based buffer (pH 8, concentration c = 0.1 M, ionic strength
I = 0.25 M). The buffer was changed daily for four days. The
reaction is depicted in Figure 1, step 2.
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Figure 1: Synthesis of the simultaneously cross-linked and thiolated PSI and PASP gels.
To prepare thiolated PASP-based hydrogels, 0.1 M dithio-
threitol (DTT) solution was used, prepared with the same
imidazole buffer that was mentioned previously. The cleavage
of the disulfide bonds leads to the formation of cysteamine mol-
ecules in the polymer matrix, which is indicated by CYSE
instead of CYS in the nomenclature. The reaction is shown in
Figure 1, step 3.
Effect of the pH value on the equilibrium
degree of swelling
To determine the pH value-dependent degree of swelling of
both the PSI- and the PASP-based gels, gel disks of three differ-
ent diameters (6, 10 and 14 mm) were prepared. The weight of
the disks was measured after reaching the equilibrium swelling
degree in DMSO (for the PSI-based gels) or in an imidazole
buffer of pH 8 (for the PASP-based gels). After that, the gel
disks were immersed in buffers with different pH values
(2.3–13.8) but the same ionic strength (c = 0.1 M, I = 0.25 M)
for two days. Then, the buffers were changed, and the weight of
the disks was measured two days later, following that the liquid
had been carefully sponged up from the outer surface of the
gels. Finally, the gels were dried at 40 °C, and the degree of
swelling was calculated as the quotient of the weight of the
swelled and the dried gel (mdried). Three parallel measurements
were carried out for each gel diameter.
Determination of the concentration of the
elastically active chains by mechanical
measurements
To measure the elastic modulus (G), gel cylinders of 1 cm in di-
ameter and height were prepared with the same constitution as
described above. G was assessed by vertical stress–strain mea-
surements using an Instron 5942 (Intest kft., Hungary) mechani-
cal tester, and its exact value was calculated by determining the
stress–strain behavior during unidirectional compression. The
temperature and the volume of the gels were constant during
deformation, therefore, the Neo–Hooken law could be used to
describe the deformation of the gels [21]:
(1)
where σN is the nominal stress and λ is the deformation ratio,
which can be calculated as the ratio of the actual height and the
initial height of the cylinder. G can be expressed as:
(2)
where R is the gas constant, T is the temperature, Φ represents
the polymer volume fraction of the gel, v* is the concentration
of the elastically active chains in the dry network (expressed in
moles), and q0 denotes the so-called memory term, by which
the network “remembers” its initial state. The molecular inter-
pretation of q0 is controversial for networks prepared in solu-
tion. A is a model-dependent parameter. According to the Flory
theory A = 1, while in the James–Guth and Staverman theories
A = 0.5 [50,51]. For the present experiments, the parameter of
the Flory theory was used. The value of ν* was calculated using
Equation 2.
Swelling of the PASP hydrogels in DTT
solution
Different PASP-XCYS-LYS gel disks of 6 mm in diameter
were prepared and immersed in a 0.1 M DTT solution at pH 8.
Changes of the concentration were avoided during the measure-
ments by using a large amount of the solution in relation to the
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gel disks. The swelling kinetics were monitored under an Alpha
ScopeTek STO-3 light microscope. Pictures were taken every
5 min during one day and the ScopePhoto program was used to
measure the diameter of the gel disks. In each case, three
parallel measurements were carried out. The relative degree of
swelling (Qrel) was calculated as a ratio of the volume of the
gels (QV) after and before the DTT treatment.
(3)
To study the effect of the DTT concentration on the swelling
degree of the gels, PASP-20CYS-LYS gels were immersed in
DTT solutions of pH 8 at different DTT concentrations
(0.001−1.6 mmol/mL). In order to avoid the oxidation of DTT,
the samples were rinsed with nitrogen gas. The weight of the
gel disks was measured before and after being treated with DTT
over five days. For all samples, two parallel measurements were
carried out. The kinetic evaluation is based on the Tanaka–Fill-
more–Peters–Candau (TFPC) theory [13].
Isolation and culturing of tooth-derived cells
The PDLCs originated from human wisdom teeth, which were
surgically removed from healthy young adults at the Depart-
ment of Dentoalveolar Surgery, Semmelweis University (ac-
cording to the ethical guidelines set by the Ethical Committee
of the Hungarian Medical Research Council). This study was
approved by the Semmelweis University Regional and Institu-
tional Committee of Science and Research Ethics. The number
of the ethical permission is: 17458/2012/EKU. After extraction,
the teeth were immediately placed into a sterile cell culture me-
dium. The viable periodontal fibers were removed from the
tooth surface, put into a sterile box with a sterile blade and
digested in 1 mL collagenase I solution (1 mg/mL, Sigma-
Aldrich, St. Louis, Missouri) for 1 h at 37 °C. The samples
were vortexed every 10 min. After digestion, the fibers were
mechanically loosened with needles (21G and 18G) and were
centrifuged for 5 min at 250g.
The PDLCs were maintained in a humidified incubator (Nuaire,
USA) in 100 mm tissue culture dishes (Orange Scientific,
Belgium) under standard culture conditions (37 °C, 5% CO2,
100% humidity). The growth medium of the PDLCs was the
following. Eagle’s Minimal Essential Medium Alfa (αMEM)
(Gibco, USA) was supplemented with 10% fetal bovine serum
(FBS, Gibco, USA), 2 mM ʟ-glutamine (Gibco, USA),
100 units/mL penicillin and 100 mg/mL streptomycin (Gibco,
USA). When the cell culture became subconfluent, it was
passaged at a ratio of 1:20 using a 0.05% trypsin/EDTA solu-
tion.
Cell viability assay
Before performing the cell viability assay, the PASP-based gel
disks of different constitutions were incubated in the above-
mentioned growth medium for 3 h with a medium change after
1.5 h. After incubation, the gel disks were placed into low cell-
binding plates (96-well plates, NuncTM Dishes, St.Louis,
Missouri) and sterilized by UV radiation for 1 h. Subsequently,
20,000 PDLCs were seeded on each gel disk in 200 μL medi-
um and cultured for one or three days. Afterwards, each well
was washed with PBS (37 °C) to remove swimming or loosely
attached cells. To measure the cell viability, a colorimetric
assay was performed using the cell proliferation reagent WST-
1. The reagent was diluted (1:20) with αMEM containing no
phenol red (Gibco, USA). Then, 200 μL solution was applied in
each well. After incubation for 2 h at 37 °C, 150 μL of the
supernatant solution was transferred from each well into an
empty 96-well plate. The absorbance was measured at 450 nm
using a microplate reader (Model 3550, Bio-Rad Laboratories,
Japan) with a reference wavelength of 655 nm. Gel disks with-
out cells were used as background controls.
Microscopic study of the cells
To visualize the PDLCs, the cells were labelled with a vital dye
called Vybrant DiD (Molecular Probes, USA) before seeding.
Gel disks of 5 mm diameter were placed into 48-well plates,
and 40,000 cells per well were seeded in 400 μL medium. After
1 or 3 days, the wells were washed with PBS (37 °C) and fixed
in 4% paraformaldehyde (in PBS) at room temperature for 2 h.
The fixed samples were washed twice and then stored in PBS at
4 °C. The examination was carried out under a two-photon
microscope (Femto2d, Femtonics, Hungary). A SpectraPhysics
DeepSee laser was used at a wavelength of 800 nm to excite the
photoactive dye. Images were taken with a 10x objective by the
MES4.4v program. The cells can be seen in red color, while
green indicates the autofluorescence of the PASP-based gels.
Statistical analysis
To assess the cell viability, PDLC cultures derived from five
different patients were used, and five parallel measurements
were carried out for each culture. The arithmetic mean and the
standard error of the mean (SEM) are indicated in the diagrams.
The statistical evaluation of the data was performed by the
STATISTICA 10 software applying the Kruskal−Wallis
nonparametric ANOVA test followed by a median test. A
derived difference was regarded as statistically significant if the
probability value is smaller than 0.05 (p < 0.05).
Drug release measurement
For the drug release measurement metoprolol was used as a
model drug. Gel disks with a thickness of 0.75 mm and a diam-
eter of 6 mm were swelled in physiological saline solution to
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2584
Figure 2: The dependence of the mass swelling degree of (a) the PSI- and (b) the PASP-based gels on the pH value.
reach the equilibrium swelling degree. After that, they were
immersed in 100 mg/mL metoprolol tartrate (Sigma-Aldrich)
solution for three days, and then the solution was carefully
sponged up from the gel surface prior to the measurement. The
release of the metoprolol was measured in 20 mL physiological
saline solution (cNaCl = 9 g/L, pH 5.5) and in 20 mL 0.1 M DTT
(in physiological saline solution). The drug release was fol-
lowed by a JASCO V-650 spectrophotometer at 274 nm with an
optical fiber probe. The concentration of the released meto-
prolol was calculated using the calibration line (Supporting
Information File 1, Figure S1). The mass of the gel disks was
measured before the experiment. The concentration was divided
by the corresponding mass of the gel to compensate for varia-
tions of the gel mass during the parallel measurements.
Results and Discussion
Influence of the pH value on the equilibrium
degree of swelling of PSI and the
PASP-XCYS-LYS hydrogels
For applications in the field of tissue engineering, the swelling
behavior of the amino acid-based hydrogels needs to be deter-
mined. Ideally, the swelling properties of the hydrogel scaffold
should not change during the application. However, different
cell types require scaffolds with different swelling properties
(and also different stiffness). The PSI-based gels show a low
swelling degree at pH 8 due to the hydrophobic character of the
PSI backbone (Figure 2a). Since PSI is insoluble in water, the
Huggins interaction parameter increases in an aqueous medium,
hence, the gels shrink. Between pH 6 and 8, the swelling
degrees abruptly rise as the polymer networks are hydrolyzed.
The successful hydrolysis was proved by FTIR spectroscopy
(Supporting Information File 1, Figure S2). This kind of abrupt
change was described in previous articles, where other mole-
cules or only LYS were applied as cross-linkers [21,22,34]. Be-
tween pH 8 and 11, the swelling degrees remain approximately
constant, as has been observed for other types of PASP-based
hydrogels [21,22,34]. However, for pH values larger than 11, a
further increase in the swelling degree is observed (Figure 2a).
This increase is due to the cleavage of the disulfide bonds in
CYS, as we described in our previous article for DAB and CYS
cross-linked hydrogels [21]. Another reason for the swelling
can be the hydrolysis of the ester bond in LYS, which increases
the concentration of negatively charged groups in the polymer
matrix. The PSI-0CYS-LYS gel shows a significantly higher
swelling degree at every pH value due to the smaller reactivity
of the amine groups in LYS, which leads to a lower amount of
cross-links [21].
Regarding the mass swelling degree of the PASP-based hydro-
gels, two groups can be observed which differ in the ratio of the
LYS and the CYS cross-linkers (Figure 2b). The gels with a
lower ratio of LYS cross-links (100, 80 and 60CYS-LYS) have
a lower swelling degree than the gels with higher LYS concen-
tration (40, 20 and 0CYS-LYS) at every pH value, which also
proves the lower reactivity of LYS. The highest swelling degree
was measured around pH 6, except for PASP-100CYS-LYS, in
which every carboxyl group on the side chains of the aspartic
acid monomers is deprotonated. By simultaneously using DAB
or DAB/CYS as cross-linking agents, the degree of swelling is
increasingly sharp in the range of pH 3–5 [22]. However, the
use of LYS causes a monotonic increase of the swelling degree
in the acidic pH range due to the free amine groups in the LYS
side chain. Protonation of the free amine groups in CYS and
LYS results in a decrease of the swelling degree between pH 6
and 10. However, for the DAB cross-linker, the degree of
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Figure 3: (a) Swelling and (b) dissolution kinetics of different PASP-XCYS-LYS gels in 0.1 M DTT solution at pH 8. (c) Description of the swelling
kinetics by THB theory [12] and (d) images of the gels before and after swelling.
swelling remained constant at alkaline pH values as we
published in our previous paper [21,22,45]. The further increase
of the swelling degree at pH values larger than 12 is the conse-
quence of the cleavage of the disulfide bond of CYS and the
hydrolysis of the ester group in the LYS cross-linkers. These
findings are in a good agreement with our previous study. Yet,
the LYS cross-linker shows a rather different dependence on the
pH value than the DAB cross-linker, which could enhance the
applicability of these hydrogels as scaffolds for cell culturing
[25].
Swelling kinetics of PASP gels in the
presence of DTT
The disulfide bonds in the PASP-based hydrogels are sensitive
to the redox potential of the local environment [21,34,45].
Therefore, in the presence of a reductive agent such as DTT, the
disulfide bonds can be cleaved and the gel can swell in the same
way as it can happen under physiological conditions or in vitro.
In this section, we demonstrate the results of the swelling
kinetics in the presence of DTT (Figure 3).
Figure 3a and Figure 3b show the changes of the relative
volume degree of the swelling (Qrel) of the gels dissolved in
0.1 M DTT at pH 8. The 0CYS-LYS gel is not sensitive to the
DTT solvent because it does not contain any disulfide bonds.
Due to the polyelectrolyte character of PASP, the small but fast
increase of Qrel for PASP-0CYS-LYS is most likely caused by
the small change of the ionic concentration of the solution
(Figure 3a and Figure 3d) [52]. The swelling degree of the
20CYS-LYS gel increases significantly (73%) in the presence
of DTT within 2 h, which proves the cleavage of the disulfide
bonds in the CYS cross-linkers. Due to the higher cross-linking
ability of CYS compared to LYS, Qrel increases almost by a
factor of two in these gels although CYS represents only 20%
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Figure 4: Dependence of the relative swelling degree of the PASP-20CYS-LYS gel on the amount of DTT a) between 0 and 1.6 mmol DDT and
b) between 0 and 0.04 mmol DTT.
of the total cross-linker molecules. For other permanent cross-
linkers, such as DAB [21] or poly(ethylene glycol) diglycidyl
ether [34], the reduction of the disulfide bonds leads to a lower
swelling degree, which also proves the previously mentioned
theory. Upon increasing the density of the CYS molecules
further, the gels abruptly degrade and dissolve after a few
minutes (8–10 min), since the cross-linking density reaches the
critical value at which the osmotic pressure bursts the polymer
matrix [53].
To describe the swelling kinetics of the 0CYS-LYS and
20CYS-LYS samples, the TFPC theory was used as has been
shown in our previous article [13] (Table 2).
Table 2: Swelling kinetics data of the different gels.
Sample Final Qrel r(0) (mm) r(∞) (mm) τ (min)
0CYS-LYS 1.09 5.95 6.24 8.69 ± 0.7
20CYS-LYS 1.72 5.95 7.15 41.67 ± 2.1
The swelling of the two hydrogels is based on different pro-
cesses. The swelling of the 0CYS-LYS hydrogel occurs due to
changes of the ionic strength, while the swelling of the 20CYS-
LYS hydrogel is induced by the cleavage of the disulfide bonds.
The change of the ionic strength is a faster process, therefore,
the relaxation time determined for the 0CYS-LYS hydrogel is
smaller than that of the 20CYS-LYS hydrogel.
Dependence of the swelling degree of the
PASP-20CYS-LYS gels on the amount of
DTT in the environment
In order to investigate whether every disulfide bond in the gel
disks has been cleaved in the previous experiment and to get a
better view of the fate of the scaffold during possible future
therapeutic applications, the changes of the swelling degree
were measured in the presence of different amounts of DTT.
The amount of disulfide bonds was determined in the PASP-
20CYS-LYS gels (Figure 4).
The relative swelling degree (Qrel) shows a monotonic increase
with the increasing amount of DTT up to about 0.03 mmol
(Figure 4). Elevating the amount of DTT, no further changes in
Qrel can be seen. In order to determine the amount of disulfide
bridges in the gel, a linear regression line was fitted to the first
part of the measurement points (0−0.03 mmol DTT) and the
constant part (0.03−1.6 mmol DTT) (Figure 4b). The x-coordi-
nate of the intersection point of the two lines gives the
minimum amount of DTT (0.025 mmol) that can cleave the
total amount of the disulfide bridges. Hence, this amount it is
equal to the molar amount of the disulfide bonds in the gel
matrix. According to these data, the amount of disulfide bonds
in the cross-linkers of the PASP-20CYS-LYS hydrogels is
around 0.025 mmol, which is equal to the amount of CYS
cross-linkers applied in the synthesis (see above). These results
prove that each disulfide bond in the PASP-20CYS-LYS hydro-
gels has been cleaved by DTT in the described experiments
(Figure 3). Due to the dissolution of the hydrogels containing
higher amounts of CYS cross-linkers, this method cannot be
used to determine the amount of disulfide bonds in these gels.
It is a challenging task to determine the cross-linking density in
a polymer matrix. Usually, stress–strain measurements are used
for this purpose. However, their results are influenced not only
by the density of the chemical cross-links but also by the physi-
cal interactions between the polymer matrix and the swelling
agent as well as other thermodynamic parameters [21,50,51,54-
56]. Consequently, the swelling behavior of different hydrogels
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Figure 5: Dependence of the elastic modulus G (black squares, blue triangles) and the concentration of the elastically active chains v*q0−2/3 (red
dots, green triangles) on the CYS/LYS molar ratio in a) DMSO, b) imidazole buffer (pH 8, c = 0.1 M, I = 0.25 M) and c) PBS (pH 7.4, I = 0.15 M).
d) Gel cylinders before and after DTT treatment.
needs to be investigated in depth, and the relation between the
swelling and other thermodynamic parameters is still to be de-
termined. However, such measurements are difficult and require
expensive equipment. By the presented method, the number of
chemical cross-links can be determined by cleaving the sensi-
tive bonds in the cross-linkers. The changes of the swelling
degree as a function of the concentration of the reactant reveal
the density of the sensitive bonds. This method is not reported
in the literature about polymer gels. Thus, it can be regarded as
a novel protocol for the determination of the amount of the
sensitive cross-linkers in hydrogels.
Relationship between the mechanical
properties and the chemical constitution of
the gels
The stiffness of the hydrogel scaffold is a key parameter in the
field of tissue engineering. It was described previously that dif-
ferent cell types prefer gels of different stiffness for prolifera-
tion [57]. In this section, the mechanical properties of the amino
acid-based hydrogels of different chemical constitutions will be
explained in detail.
As shown in Figure 3, the swelling properties of the PASP-
based gels significantly depend on the chemical constitution of
the gels. Consequently, the mechanical properties presumably
depend on it as well. The relationship between the molar ratio
of the two cross-linking agents (nCYS/nLYS) and the mechani-
cal properties such as the elastic modulus (G) and the concen-
tration of the elastically active chains (v*q0–2/3) can be seen in
Figure 5.
Upon increasing the CYS/LYS molar ratio, both G and ν*
monotonically increase in every solvent (Figure 5). This linear
increase provides evidence that CYS has a higher cross-linking
ability than LYS during the gel synthesis. Namely, larger
amounts of cross-links in the polymer matrix lead to higher
values of G and ν* [21]. This indicates that a larger amount of
CYS molecules reacts with two amine groups cross-linking the
polymer chains. The strong electron withdrawing character of
the carboxyl group of the amino-acid group decreases the elec-
tron density of the alpha amine group, resulting in a weaker re-
activity of LYS. Supposedly, most LYS molecules react only
with their side chain amine groups, and the gelation time is
longer if the ratio of LYS cross-linkers is higher. This behavior
can also contribute to the characteristic dependence of the gel
swelling on the pH value (see above). The cross-linking ability
of LYS can be improved by phosphoric acid catalysis as was
shown by Gyenes and co-workers [22]. However, this method
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Figure 6: a) Viability of the PDLCs measured one and three days after seeding. The average viability value measured on the 100CYS-LYS gel on day
one was considered as 100%. The cell viability indices are given as arithmetic mean ± SEM. * indicates p < 0.05 compared to the value of 100CYS-
LYS at the corresponding time. + indicates p < 0.05 compared to the value of 100CYS-LYS on day one. b) Two-photon microscopic images of the
PDLCs on the different hydrogels after three days. The scale bar indicates 200 μm. Each photomicrograph was taken at the same magnification.
cannot be used in our case because phosphoric acid precipitates
CYS immediately.
Upon hydrolysis, the ν* values increase only very slightly,
while the G values decrease (Figure 5a and Figure 5b). Neither
of these two parameters changes when replacing the imidazole
buffer (pH 8) with PBS (Figure 5b and Figure 5c). The ν*
values depend on the swelling degree of the gels (Equation 2),
which is changing during hydrolysis (Supporting Information
File 1, Table S1). Yet, the swelling degree is not influenced by
the change of the buffer from imidazole to PBS since the con-
centration of ions remains the same in both buffer solutions.
This may explain the different values of G and ν* in DMSO
(Figure 5a) but both values are similar after hydrolysis. These
findings are in accordance with our previous findings [21].
When cleaving the disulfide bonds using DTT, all gels except
for the 20CYS-LYS gel turned very soft or dissolved complete-
ly (Supporting Information File 1, Figure S2). However, the
20CYS-LYS gel did not dissolve (Figure 5d) but only swelled
and turned moderately softer after the DTT treatment. The
values of G and ν* decreased significantly (blue and green tri-
angles in Figure 5b and Figure 5c). A similar decrease has been
observed for other PASP-based CYS containing hydrogels in
which another type of nonsensitive cross-linker was applied si-
multaneously with CYS [21,34,45].
Application of the PASP-XCYS(E)-LYS gels
for cell cultivation
In addition to the elaborate characterization of the swelling and
the mechanical properties as well as the thiol content, our aim
was to study the applicability of the amino acid-based hydro-
gels as scaffolds for cell cultivation.
At first, the viability of the growth of PDLCs on the different
hydrogels was tested (Figure 6a). After one day of cell growth,
the highest cell viability index (referring to the highest cell
adhesion) was measured on the 100CYS-LYS gel, which does
not contain any LYS at all, only the redox sensitive cross-linker
CYS. On day one, the cell viability index was lower for the
20CYS-LYS gel and the 40CYS-LYS gel than for the 100CYS-
LYS gel. Still, for both gels, it had doubled after three days of
cell growth suggesting that a lower CYS concentration favors
cell proliferation. This result is presumably related to the en-
Beilstein J. Nanotechnol. 2019, 10, 2579–2593.
2589
hanced elastic modulus of the hydrogels (see above) as well as
the relatively low LYS concentration. These results are in
accordance with our previous work where we demonstrated that
exchanging half of the CYS cross-linkers by DAB improved the
proliferation of osteosarcoma cells [25]. However, the aim of
the present study is to prepare gels composed of amino acids
exclusively and test their biocompatibility on healthy cells. The
disulfide bonds in the polymer matrix were supposedly cleaved
in the cell medium during the three days of incubation which
results in the formation of thiol groups in the hydrogel. The
presence of thiol groups supports cell adhesion and prolifera-
tion as we showed previously. Therefore, the higher the density
of CYS in the polymer matrix, the higher is the viability of the
cells [25]. In the literature, several articles can be found about
the effect of poly-ʟ-lysine on cell adhesion and proliferation
[30,58,59]. It was elucidated that this advantageous feature of
poly-ʟ-lysine is concentration-dependent, and the amount of
poly-ʟ-lysine should be optimized to reach the highest cell
viability [30]. In our hydrogels, LYS is not polymerized but
present as a monomer and plays a role as a cross-linker. This
function of LYS in scaffolds, which is related to cell prolifera-
tion, has not been investigated before. Nevertheless, the posi-
tive effect of LYS is highly concentration-dependent. Accord-
ing to the literature, a high amount of LYS has a cytotoxic
effect, while a lower amount supports cell adhesion and prolif-
eration. Moreover, the effect of LYS can be diverse depending
on whether poly-ʟ-lysine is applied in water-soluble form [58]
or as a built-in element in scaffolds [30]. On the other hand,
LYS is a permanent cross-linker which is important to maintain
the stability of the hydrogel during the cell experiments. Based
on our results (Figure 6), the highest viability increase from day
one to day three was found for the 20CYS-LYS and 40CYS-
LYS gels, suggesting that cross-linker ratios of 60−80% LYS
and 20−40% CYS yield the highest proliferation rate of PDLCs.
The viability of cells on the 0CYS-LYS gel as well as on the
20CYSE-LYS gel, for which the disulfide bonds were previ-
ously created using the reductive agent DTT, decreased slightly
from day one to day three. The similar behavior of the cells on
these two hydrogels can be explained by the similar gel struc-
ture. Neither of these two gels contains CYS as a cross-linker,
but only LYS cross-links the polymer chains. As given in
Table 1, the initial concentration of LYS in our gels was be-
tween 0 and 1.8 wt %. A significant increase of the cell
viability from day one to day three was measured for the
40CYS-LYS gels (LYS concentration around 1.5 wt %) which
correlates with the findings of Datta et al., who found that the
addition of 1.5 wt % of LYS significantly increases the cell
viability [30].
The two-photon microscopic images (Figure 6b) confirm the
results of our viability assays. Since the cells show a red fluo-
rescence due to the vital stain applied, while the PASP-based
hydrogels show a green autofluorescence [25], the gel matrix
and the cells are easily distinguished. On day three, only few
PDLCs showed a healthy fibroblast morphology on the 0CYS-
LYS hydrogel, while the other cells had a rounded shape
suggesting that they were unable to adhere to these gels. By in-
creasing the ratio of the CYS cross-linking agents in the gel
matrix, the proportion of the viable cells became elevated. The
highest amount of PDLCs with fibroblast morphology can be
observed on the 100CYS-LYS gel, which correlates well with
the viability results.
According to the literature, various forms of lysine-containing
scaffolds are able to enhance both the adhesion and the prolifer-
ation of stem cells. The most commonly used scaffolds are
based on poly-ʟ-lysine [30,59,60] and poly-ᴅ-lysine [61]. How-
ever, LYS was applied as a cross-linker only in a few cases.
The corresponding gels are not fully composed of amino acids
or have other disadvantages compared to our gels, for example,
expensive preparation methods [62,63].
Drug release kinetics in isotonic and
reductive medium
In addition to the possible applications in tissue engineering, the
applicability of the amino acid-based hydrogels in drug delivery
is very important. Therefore, the second aim of our work was to
investigate the potential of the scaffolds as drug carriers. To get
a better understanding of the fate of the drug in the living
system, the release kinetics were determined not only in an
isotonic but also in a reductive medium. Metoprolol was chosen
as a model drug because it does not chemically interact with the
polymer backbone, but ionic interactions can occur between the
polymer matrix and the metoprolol molecules. Hence, theoreti-
cally, the only limiting factor of the release of metoprolol is
diffusion. Moreover, metoprolol can be measured easily beside
DTT by UV–vis spectroscopy.
The kinetics of the metoprolol release from the different PASP-
XCYS-LYS gels was studied in both physiological saline
(NaCl) and DTT solution (Figure 7). The graph depicts the re-
leased concentration of metoprolol normalized to the initial
mass of the gel disk (cmet) as a function of release time.
The drug release kinetics show a similar behavior for all gel
samples in the physiological saline solution (Figure 7, black
squares). The released metoprolol reaches the saturation con-
centration after ca. 50 min in every measurement. The satura-
tion concentration is highest for the PASP-100CYS-LYS sam-
ple reaching a concentration of 11 g/L∙ggel in physiological
NaCl. Upon decreasing the density of CYS cross-links in the
hydrogels, the saturation concentration is reduced to around
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Figure 7: Metoprolol release from the different PASP-XCYS-LYS gels (cmet) in physiological saline solution (black squares) and in 0.1 M DTT/physio-
logical saline solution (red circles).
7.5 g/L∙ggel for the 20CYS-LYS and the 0CYS-LYS hydrogel.
A possible explanation of this phenomenon is the following.
Metoprolol has a secondary amino group, which is protonated
under these conditions leading to a weak interaction with the
negatively charged PASP. As we demonstrated in previous ex-
periments, hydrogels with increasing density of CYS cross-
linkers have a higher polymer content (higher elastic modulus).
Therefore, gels of higher CYS content can take up more meto-
prolol molecules from the solution. Consequently, a higher
amount of CYS in the gel can result in a higher saturation con-
centration of metoprolol in the liquid. The kinetics curves are
very similar to normal kinetics curves of drug release indicat-
ing a burst effect [15].
The presence of DTT leads to a higher saturation concentration
of metoprolol presumably due to the cleavage of the disulfide
bonds. The dissolution of the PASP-100CYS-LYS gel in the re-
ductive medium is a continuous process. Therefore, the concen-
tration of the released metoprolol in the DTT solution was
higher than in the physiological salt solution at each measure-
ment point. For the 40CYS-LYS, the 60CYS-LYS and the
80CYS-LYS gels, the metoprolol concentration increases faster
compared to the 0CYS-LYS and the 20CYS-LYS gels in the
first 20 min of the metoprolol release, which is presumably
caused by the dissolution of the gels (Figure 3b). Although the
dissolution of the 40CYS-LYS, the 60CYS-LYS, the 80CYS-
LYS and the 100CYS-LYS gels occurs already after 10 min in
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DTT solution (Figure 3b), the concentration of metoprolol
reaches the saturation concentration only after 20 min. The
ionic interaction between the polymer backbone and meto-
prolol could slow down the dissolution of the gels, which can
cause such a difference. A higher degree of swelling leads to a
higher diffusion coefficient in the gel matrix and consequently
to a faster drug release. A similar observation was described in
the case of another PASP-based gel and different other types of
hydrogels [34]. For the PASP-20CYS-LYS gel, the drug release
kinetics do not differ significantly for the reductive medium and
the physiological solution during the first 20 min of release.
Thus, the cleavage of the disulfide bonds in PASP-20CYS-LYS
seems to be slower. After 20 min, this gel already swelled sig-
nificantly and the metoprolol concentration increased in DTT
solution. The saturated concentration reached a higher value in
the DTT solution than in the physiological saline solution by
the end of the measurement. The observation that DTT had no
influence on the drug release in the case of 0CYS-LYS
(Figure 7) is in line with the findings of our study of the
swelling kinetics, i.e., that this gel type lacks disulfide bonds
making it insensitive to the reductive environment (Figure 3a).
Conclusion
In this work, we tested the suitability of different fully amino
acid-based hydrogels for tissue engineering and drug delivery
applications. The influence of the chemical constitution of these
hydrogels on the swelling and the mechanical properties was
studied under different conditions. To prepare PASP-based
hydrogels, LYS and CYS were used as cross-linkers at differ-
ent molar ratios. Whereas LYS acts as a permanent cross-linker
in the polymer matrix, CYS is sensitive to changes of the redox
potential in the environment. Thus, the redox response of the
hydrogels significantly depends on the ratio of the two cross-
linkers. By increasing the CYS content, the swelling of the
hydrogels becomes faster in different media. According to the
mechanical tests, LYS has a lower cross-linking ability than
CYS due to the ester group in LYS (lysine methylester). There-
fore, a higher LYS content results in a lower elastic modulus
and a lower concentration of elastically active chains in the
hydrogels. The cleavage of the disulfide bonds leads to a signif-
icant decrease of the concentration of the elastically active
chains for the 20CYS-LYS gel, which highly influences the
release of metoprolol from the gel. Using different amounts of
DTT as a reducing agent, the amount of CYS as the reactive
cross-linker could be determined precisely. Human PDLCs
were used to assess the biocompatibility of the hydrogels. Their
viability also proved to depend on the ratio of the two cross-
linkers. In summary, PASP-based hydrogels are promising ma-
terials for both medical and pharmaceutical applications which
can be designed by tailoring the chemical structure of the
hydrogels.
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